19911213
 Both Xoma, Centocor Claim Partial Victory in a Patent Ruling   The Wall Street Journal,  Dec 13, 1991  A federal judge ruled that Centocor Inc must make payments to Xoma Corp for the sale of its competing drug, Centoxin. The judge denied Xoma's request for a hearing on whether to bar Centocor from marketing the drug altogether. The decision is the result of a patent dispute over a treatment for a lethal blood infection.   
